Company Overview: Chek

Industry News

27 Sep

Check-Cap Announces Filing of CE Mark Registration for C-Scan®

Management Hosts Conference call at 9:00 a.m. EDT ISFIYA, Israel and BOSTON, Sept. 27, 2017 /PRNewswire/ –Check-Cap Ltd. (the “Company” or “Check-Cap”) (CHEK) (NASDAQ:CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has filed for the CE Mark registration...

Read more

10 Aug

Check-Cap Reports Second Quarter 2017 Financial Results

ISFIYA, Israel and BOSTON, Aug. 10, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the second quarter and six...

Read more

2 Jun

Check-Cap Ltd. Announces Closing of $2.69 Million Financing

ISFIYA, Israel and BOSTON, June 2, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced the closing of the previously announced definitive agreement with a...

Read more

30 May

Check-Cap Ltd. Announces $2.69 Million Financing

ISFIYA, Israel and BOSTON, May 30, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has entered into a definitive agreement with a single...

Read more

9 May

Check-Cap Reports First Quarter 2017 Financial Results

ISFIYA, Israel, May 9, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK; NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the three...

Read more

9 Mar

Check-Cap Reports Fourth Quarter and Fiscal Year 2016 Financial Results

ISFIYA, Israel, March 9, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the fourth quarter...

Read more

1 Mar

Check-Cap to Present at the 29th Annual ROTH Conference on March 14, 2017

ISFIYA, Israel, March 1, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer (CRC) screening, today announced that Bill Densel, Chief Executive Officer, will present at the 29th...

Read more

Page 1 of 3123

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address